Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Chubb
Mallinckrodt
Farmers Insurance
Fuji
Chinese Patent Office
US Department of Justice
QuintilesIMS
Citi

Generated: April 25, 2018

DrugPatentWatch Database Preview

SELFEMRA Drug Profile

« Back to Dashboard

Which patents cover Selfemra, and what generic alternatives are available?

Selfemra is a drug marketed by Teva Pharms Usa and is included in one NDA.

The generic ingredient in SELFEMRA is fluoxetine hydrochloride. There are twenty-seven drug master file entries for this compound. Fifty-nine suppliers are listed for this compound. Additional details are available on the fluoxetine hydrochloride profile page.
Drug patent expirations by year for SELFEMRA
Synonyms for SELFEMRA
(+-)-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine hydrochloride
(+-)-N-Methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-p-tolyl)oxy)propylamine, hydrochloride
(+-)-N-Methyl-3-phenyl-3-(4-(trifluoromethyl)phenoxy)propylamine hydrochloride
(+/-)-FLUOXETINE HYDROCHLORIDE
(+/-)-N-Methyl-3-phenyl-3-[(alpha,alpha,alpha-trifluoro-p-tolyl)oxy]propylamine, HCl
(+/-)-N-Methyl-gamma-[4-(trifluoromethyl)phenoxy]benzenepropanamine hydrochloride
(S)-N-Methyl-3-phenyl-3-(4-(trifluoromethyl)phenoxy)propan-1-amine
3-(p-Trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine hydrochloride
54910-89-3 (Parent)
56296-78-7
59333-67-4
910F893
AB04860
AB2000053
AC-1697
AC1L1XXD
Adofen
Affectine
AK163170
AKOS015894939
Alental
Alzac 20
AN-14688
AN-40216
ANW-42507
Apo-Fluoxentine
BC208532
BENZENEPROPANAMINE, N-METHYL-G-[4-(TRIFLUOROMETHYL)PHENOXY]-, HYDROCHLORIDE (1:1)
Benzenepropanamine, N-methyl-gamma-(4-(trifluoromethyl)phenoxy)-, hydrochloride
Benzenepropanamine, N-methyl-gamma-(4-(trifluoromethyl)phenoxy)-, hydrochloride, (+-)-
Bioxetin
C17H18F3NO.HCl
CAS-56296-78-7
CCG-39084
CCRIS 6150
CHEMBL1201082
CPD000058452
Cramin
CS-1838
CTK8B3427
D00823
Depreks
Deproxin
Digassim
dl-N-Methyl-3-(p-trifluoromethylphenoxy)-3-phenylpropylamine, HCl
DR001730
DSSTox_CID_635
DSSTox_GSID_20635
DSSTox_RID_75706
DTXSID7020635
EINECS 260-101-2
Equilibrane
Erocap
EU-0100558
F-132
F0750
Felicium
Fluctin
Fluctine
Fludac
Fludeka
Flufran
Fluneurin
Flunil
Flunirin
Fluox-Puren
Fluoxac
Fluoxeren
Fluoxetin HCl
Fluoxetine HCl
Fluoxetine (hydrochloride)
Fluoxetine Hcl
FLUOXETINE HYDROCHLORIDE
Fluoxetine hydrochloride (JAN/USP)
Fluoxetine hydrochloride [USAN:USP]
Fluoxetine hydrochloride [USAN]
Fluoxetine Hydrochloride 1.0 mg/ml in Methanol (as free base)
Fluoxetine hydrochloride solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material
Fluoxetine hydrochloride, British Pharmacopoeia (BP) Reference Standard
Fluoxetine hydrochloride, European Pharmacopoeia (EP) Reference Standard
Fluoxetine Hydrochloride, pharmaceutical secondary standard; traceable to USP, PhEur and BP
Fluoxetine hydrochloride, solid
Fluoxetine hydrochloride, United States Pharmacopeia (USP) Reference Standard
Fluoxetine hydrochloride, VETRANAL(TM), analytical standard
Fluoxetine hydrochoride
Fluoxetine, Hydrochloride
Fluoxetine.HCl
FluoxetineHydrochloride
Fluoxifar
Fluoxil
Flutin
Flutine
Fluxen
Fluxene
Fluxil
Fondur
Fonzac
Foxetin
Framex
FT-0626490
FT-0652216
GIYXAJPCNFJEHY-UHFFFAOYSA-N
HMS1569H03
HMS1922F07
HSDB 6633
HY-B0102A
I06-0079
I06-079
IN1336
J-521372
J10277
KM0299
KS-00000JJ6
KS-1061
Lilly 110140
Lorien
Lovan
LP00558
LS-185085
LS-31041
LS-7403
LY 110140
LY-110,140 hydrochloride
LY-110140
LY110140
Margrilan
methyl({3-phenyl-3-[4-(trifluoromethyl)phenoxy]propyl})amine hydrochloride
METHYL(3-PHENYL-3-(4-(TRIFLUOROMETHYL)PHENOXY)PROPYL)AMINE HYDROCHLORIDE
Methyl(3-phenyl-3-(4-(trifluoromethyl)phenoxy)propyl)ammonium chloride
METHYL(3-PHENYL-3-[4-(TRIFLUOROMETHYL)PHENOXY]PROPYL)AMINE, CHLORIDE
MFCD00214288
Mitilase
MLS000069361
MLS001076338
MLS002222264
Modipran
MolPort-003-666-535
Motivone
Mutan
Mutin
N-METHYL-3-[(4-TRIFLUOROMETHYL)PHENOXY]-3-PHENYLPROPYLAMINE HYDROCHLORIDE
N-methyl-3-phenyl-3-(4-(trifluoromethyl)phenoxy)propan-1-amine hydrochloride
N-Methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]-1-propanamine hydrochloride (1:1)
N-Methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]-1-propylamine Hydrochloride
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine hydrochloride
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine;hydrochloride
N-Methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propylamine Hydrochloride
N-methyl-3-phenyl-3-{[4-(trifluoromethyl)phenyl]oxy}propan-1-amine hydrochloride
NC00715
NCGC00093943-01
NCGC00093943-02
NCGC00093943-03
NCGC00093943-04
NCGC00093943-05
NCGC00257736-01
NCGC00261243-01
Neupax
Nopres
NPL-2008
NSC-714457
NSC-758685
NSC714457
NSC758685
Nuzak
Nycoflox
Opera_ID_1538
OR162195
OR206941
Oxedep
Pharmakon1600-01504173
Pragmaten
Prestwick_798
Prizma
Proctin
Prodep
Profluzac
Propylamine, N-methyl-3-phenyl-3-(p-trifluoromethylphenoxy)-, hydrochloride
Prozac
Prozac (TN)
Prozac 20
Prozac; LY-110,140 hydrochloride
Prozac;Sarafem
PROZAC(R) HYDROCHLORIDE
Psipax
Reconcile
RL04127
Rowexetina
s1333
SAM002589965
Sanzur
Sarafem
Saurat
SBB066066
SC-12129
SC-53387
SCHEMBL33384
Seronil
Sinzac
Siquial
SMR000058452
SPECTRUM1504173
SR-01000002988
SR-01000002988-2
ST24047216
Tox21_200182
Tox21_500558
TRA-0205161
TRA0057937
TRA0075235
Tuneluz
Verotina
Z1741982921
Zactin
Zedprex
Zepax

US Patents and Regulatory Information for SELFEMRA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Pharms Usa SELFEMRA fluoxetine hydrochloride TABLET;ORAL 200151-001 Feb 3, 2014 AB1 RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Teva Pharms Usa SELFEMRA fluoxetine hydrochloride TABLET;ORAL 200151-002 Feb 3, 2014 AB1 RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Teva Pharms Usa SELFEMRA fluoxetine hydrochloride TABLET;ORAL 200151-003 Feb 3, 2014 AB1 RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
QuintilesIMS
Argus Health
Dow
Healthtrust
Merck
Mallinckrodt
Federal Trade Commission
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.